Efficacy of baricitinib for the treatment of systemic lupus erythematosus patients: A meta-analysis of randomized controlled trials.

Aditya Kumar PandaShovit RanjanJayanta K Sahu

Published in: International journal of rheumatic diseases (2023)

In treating SLE patients, administrating a higher dose of baricitinib (4 mg) may be effective. However, additional RCTs in different populations with larger sample sizes are required to validate our findings.

Keyphrases

systemic lupus erythematosus
end stage renal disease
newly diagnosed
chronic kidney disease
systematic review
peritoneal dialysis
prognostic factors
disease activity
rheumatoid arthritis
patient reported outcomes
combination therapy